Medicina
Departamento
Instituto de Salud Pública y Laboral de Navarra
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Pública y Laboral de Navarra (17)
2018
-
Interaction between cardiovascular risk factors and body mass index and 10-year incidence of cardiovascular disease, cancer death, and overall mortality
Preventive Medicine, Vol. 107, pp. 81-89
-
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523
2017
-
Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
PLoS ONE, Vol. 12, Núm. 6
-
Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM)
Epidemiology and Infection, Vol. 145, Núm. 4, pp. 715-722
2016
-
Risk of cause-specific death in individuals with diabetes: A competing risks analysis
Diabetes Care, Vol. 39, Núm. 11, pp. 1987-1995
-
Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15
Vaccine, Vol. 34, Núm. 20, pp. 2371-2377
2015
-
Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data
Eurosurveillance, Vol. 20, Núm. 28
-
Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014
Vaccine, Vol. 33, Núm. 29, pp. 3276-3280
-
Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design
Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315
2014
-
Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study
Preventive Medicine, Vol. 61, pp. 66-74
-
Influenza vaccine effectiveness in Spain 2013/14: Subtype-specific early estimates using the cycEVA study
Eurosurveillance, Vol. 19, Núm. 9
2013
-
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination
BMC Infectious Diseases, Vol. 13, Núm. 1
2012
2009
-
Estudio de seroprevalencia de hepatitis B en deportistas de orientación
Medicina Clinica, Vol. 132, Núm. 17, pp. 649-653
2007
-
Estimating the burden of scleroderma disease in Spain
Journal of Rheumatology, Vol. 34, Núm. 11, pp. 2236-2242
2006
-
Vacuna antinicotínica
Revista Médicas UIS, Vol. 19, Núm. 3
2003
-
Recomendaciones para el Tratamiento del Tabaquismo
Archivos de Bronconeumologia, Vol. 39, Núm. 11, pp. 514-523